Troy Wuertz
Ikarian Capital, Llc
Assets Managed
$1.232B
Holdings
139
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-3.84%(2Q avg: 12.75%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Ikarian Capital, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 139 positions.
Assets under management
The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.232B in assets, with a quarterly growth rate of -3.84% and a 2-quarter average growth rate of 12.75%. The portfolio is managed by Troy Wuertz, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
TERN Terns Pharmaceuticals Inc
| 11.38% | $140.044M 2.656M shares@ $52.72 avg price | Increased 66.41% |
XBI Spdr S&p Biotech Etf
| 8.3% | $102.184M↓ Put 800,000 shares@ $127.73 avg price | Decreased -5.88% |
CYTK Cytokinetics Inc
| 6.65% | $81.891M 1.242M shares@ $65.92 avg price | Increased 168.03% |
QQQ Invesco Qqq Trust Series 1
| 4.69% | $57.718M↓ Put 100,000 shares@ $577.18 avg price | New Position |
KOD Kodiak Sciences Inc
| 4.23% | $52.064M 1.366M shares@ $38.13 avg price | Increased 89.75% |
IWM Ishares Russell 2000 Etf
| 4.03% | $49.6M↓ Put 200,000 shares@ $248.0 avg price | New Position |
ABVX Abivax Sa-adr
| 3.16% | $38.892M 350,935 shares@ $110.83 avg price | Increased 6% |
ALMS Alumis Inc
| 2.65% | $32.564M 1.478M shares@ $22.03 avg price | Increased 600.22% |
BMY Bristol-myers Squibb Co
| 2.47% | $30.325M↓ Put 500,000 shares@ $60.65 avg price | New Position |
CAPR Capricor Therapeutics Inc
| 2.17% | $26.692M 878,015 shares@ $30.4 avg price | Increased 51.91% |
1-10 of 139